Ian Estepan - Jan 29, 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Chief Financial Officer
Signature: /s/ Cristin Rothfuss, as Attorney-in-Fact for Ian M. Estepan
Stock symbol: SRPT
Transactions as of: Jan 29, 2025
Transactions value $: -$117,454
Form type: 4
Date filed: 1/31/2025, 08:30 PM
Previous filing: Dec 30, 2024
Next filing: Feb 13, 2025

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Options Exercise	$171K	+14.3K	+42.34%	$12.00	48K	Jan 29, 2025	Direct
transaction	SRPT	Common Stock	Options Exercise	$18.4K	+1.53K	+3.2%	$12.00	49.5K	Jan 29, 2025	Direct
transaction	SRPT	Common Stock	Tax liability	-$307K	-2.61K	-5.28%	$117.51	46.9K	Jan 29, 2025	Direct	F1

Showing 1 to 3 of 3 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRPT	Stock Option (right to buy)	Options Exercise	$0	-14.3K	-100%	$0.00	0	Jan 29, 2025	Common Stock	14.3K	$12.00	Direct
transaction	SRPT	Stock Option (right to buy)	Options Exercise	$0	-1.53K	-100%	$0.00	0	Jan 29, 2025	Common Stock	1.53K	$12.00	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy tax witholding obligations and payment by the Reporting Person of the option exercise price. The Reporting Person holds the exercised shares not withheld by the Issuer.